Eton Pharmaceutcials
ETON
31 hedge funds and large institutions have $15.1M invested in Eton Pharmaceutcials in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 6 closing their positions.
23% more capital invested
Capital invested by funds: $12.3M → $15.1M (+$2.81M)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
1.61% less ownership
Funds ownership: 25.08% → 23.47% (-1.6%)
3% less funds holding
Funds holding: 32 → 31 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$220K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$43.6K |
| 3 |
Jane Street
New York
|
+$40.9K |
| 4 |
KIA
Kraematon Investment Advisors
Braintree,
Massachusetts
|
+$6.18K |
| 5 |
Morgan Stanley
New York
|
+$3.74K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$944K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$248K |
| 3 |
Millennium Management
New York
|
-$87K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$42K |
| 5 |
JP Morgan Chase
New York
|
-$28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WIM
26
Westside Investment Management
Santa Monica,
California
| $3.01K | +$220K | +81,850 | +17% |
|
|
PMFA
27
Plante Moran Financial Advisors
Southfield,
Michigan
| $2.82K | – | – | – |
|
28
Fidelity Investments
Boston,
Massachusetts
| $2.52K | +$2.42K | +900 | New |
|
29
BNP Paribas Financial Markets
Paris,
France
| $987 | – | – | – |
|
30
Bank of America
Charlotte,
North Carolina
| $140 | +$134 | +50 | New |
|
|
LC
31
Lindbrook Capital
Calabasas,
California
| $11 | – | – | – |
|
|
32
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$248K | -92,380 | Closed |
|
|
33
Millennium Management
New York
| – | -$87K | -41,258 | Closed |
|
|
34
Citadel Advisors
Miami,
Florida
| – | -$42K | -19,859 | Closed |
|
|
35
JP Morgan Chase
New York
| – | -$28K | -13,278 | Closed |
|
36
Group One Trading
Chicago,
Illinois
| – | -$1.64K | -608 | Closed |
|
ETON Hedge Fund Activity: Q4 2022 in Review
31 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q4 2022, worth a combined $15.1M — up 23% from $12.3M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ETON and 5 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 6 added.
The largest buyer was Westside Investment Management, adding an estimated $220K. The largest seller was Opaleye Management, cutting an estimated $944K.
- 31 institutional investors held Eton Pharmaceutcials (ETON) as of Q4 2022, down from 32 in Q3 2022.
- Funds reported $15.1M of Eton Pharmaceutcials stock for Q4 2022, up 23% quarter-over-quarter.
- 5 funds opened new Eton Pharmaceutcials positions in Q4 2022 and 6 closed out, a net change of -1 holder.
- The largest Eton Pharmaceutcials buyer in Q4 2022 was Westside Investment Management, an estimated $220K added.
- The largest Eton Pharmaceutcials seller in Q4 2022 was Opaleye Management, an estimated $944K sold.
Based on aggregated 13F filings for Q4 2022.